- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/14 - Human serum albumins
Patent holdings for IPC class C12N 15/14
Total number of patents in this class: 45
10-year publication summary
2
|
2
|
2
|
0
|
1
|
2
|
4
|
1
|
6
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Shenzhen Protgen Ltd. | 10 |
5 |
JCR Pharmaceuticals Co., Ltd. | 221 |
4 |
Tonghua Anrate Biopharmaceutical Co., Ltd | 11 |
3 |
Adverum Biotechnologies, Inc. | 93 |
2 |
BASF Plant Science Company GmbH | 317 |
2 |
Medicago Inc. | 138 |
2 |
Soonchunhyang University Industry Academy Cooperation Foundation | 184 |
2 |
Sylvan, Inc. | 35 |
2 |
Novartis AG | 10730 |
1 |
F. Hoffmann-La Roche AG | 7941 |
1 |
Amgen Inc. | 4106 |
1 |
Agency for Science, Technology and Research | 3639 |
1 |
Ambrx, Inc. | 183 |
1 |
Amgen Research (Munich) GmbH | 257 |
1 |
ARK Diagnostics, Inc. | 34 |
1 |
Eli Lilly and Company | 3878 |
1 |
Food Industry Research & Development Institute | 12 |
1 |
Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences | 122 |
1 |
National University Corporation Kumamoto University | 391 |
1 |
Sylvan America, Inc. | 24 |
1 |
Other owners | 11 |